1. Home
  2. NKTX vs DPRO Comparison

NKTX vs DPRO Comparison

Compare NKTX & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$1.81

Market Cap

147.7M

Sector

Health Care

ML Signal

HOLD

Logo Draganfly Inc.

DPRO

Draganfly Inc.

HOLD

Current Price

$6.89

Market Cap

169.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTX
DPRO
Founded
2015
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
147.7M
169.4M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
NKTX
DPRO
Price
$1.81
$6.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$13.25
$15.67
AVG Volume (30 Days)
684.9K
2.0M
Earning Date
11-10-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,335,758.00
Revenue This Year
N/A
$39.47
Revenue Next Year
N/A
$155.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.74
52 Week Low
$1.31
$1.63
52 Week High
$3.16
$14.40

Technical Indicators

Market Signals
Indicator
NKTX
DPRO
Relative Strength Index (RSI) 40.37 42.81
Support Level $1.77 $6.42
Resistance Level $1.93 $7.70
Average True Range (ATR) 0.09 0.78
MACD 0.01 -0.01
Stochastic Oscillator 30.00 34.81

Price Performance

Historical Comparison
NKTX
DPRO

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About DPRO Draganfly Inc.

Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.

Share on Social Networks: